CGH
IONS icon

Crossmark Global Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Crossmark Global Holdings’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
3,615
+416
+13% +$31.3K ﹤0.01% 1083
2026
Q1 		$240K Buy
3,199
+97
+3% +$7.66K ﹤0.01% 1126
2025
Q4 		$245K Buy
+3,102
New +$234K ﹤0.01% 1106
2018
Q1 		– Sell
-5,096
Closed -$256K – 1602
2017
Q4 		$256K Buy
5,096
+78
+2% +$4.28K 0.01% 1463
2017
Q3 		$254K Buy
+5,018
New +$263K 0.01% 1424
2016
Q3 		$254K Buy
+5,018
New +$157K 0.01% 1424

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
CC
Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return

Crossmark Global Holdings's IONS Position: Q2 2026 in Review

Crossmark Global Holdings increased its Ionis Pharmaceuticals (IONS) stake by 13% in Q2 2026, buying an estimated $31.3K and bringing the position to 3,615 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Crossmark Global Holdings first reported a position in IONS in Q3 2016 and has held it in 6 quarters since. 45 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Crossmark Global Holdings held 3,615 shares of Ionis Pharmaceuticals worth $287K as of Q2 2026.
  • Crossmark Global Holdings bought 416 Ionis Pharmaceuticals shares in Q2 2026, an estimated $31.3K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1083 holding.
  • Crossmark Global Holdings first reported a position in Ionis Pharmaceuticals in Q3 2016 and has held it in 6 quarters since.
  • 45 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.